PMID- 18190939 OWN - NLM STAT- MEDLINE DCOM- 20080505 LR - 20161124 IS - 0041-008X (Print) IS - 0041-008X (Linking) VI - 227 IP - 3 DP - 2008 Mar 15 TI - Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS. PG - 477-84 LID - 10.1016/j.taap.2007.11.018 [doi] AB - The toxic equivalency factor (TEF) approach was employed to compare immunotoxic potency of mixtures containing polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans and polychlorinated biphenyls relative to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), using the antibody response to sheep erythrocytes (SRBC). Mixture-1 (MIX-1) contained TCDD, 1,2,3,7,8-pentachlorodibenzo-p-dioxin (PeCDD), 2,3,7,8-tetrachlorodibenzofuran (TCDF), 1,2,3,7,8-pentachlorodibenzofuran (1-PeCDF), 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF), and 1,2,3,4,6,7,8,9-octachlorodibenzofuran (OCDF). Mixture-2 (MIX-2) contained MIX-1 and the following PCBs, 3,3',4,4'-tetrachlorobiphenyl (IUPAC No. 77), 3,3',4,4',5-pentachlorobiphenyl (126), 3,3',4,4',5,5N-hexachlorobiphenyl (169), 2,3,3',4,4'-pentachlorobiphenyl (105), 2,3',4,4',5-pentachlorobiphenyl (118), and 2,3,3',4,4',5-hexachlorobiphenyl (156). The mixture compositions were based on relative chemical concentrations in food and human tissues. TCDD equivalents (TEQ) of the mixture were estimated using relative potency factors from hepatic enzyme induction in mice [DeVito, M.J., Diliberto, J.J., Ross, D.G., Menache, M.G., Birnbaum, L.S., 1997. Dose-response relationships for polyhalogenated dioxins and dibenzofurans following subchronic treatment in mice. I .CYP1A1 and CYP1A2 enzyme activity in liver, lung and skin. Toxicol. Appl. Pharmacol. 130, 197-208; DeVito, M.J., Menache, G., Diliberto, J.J., Ross, D.G., Birnbaum L.S., 2000. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls. Toxicol. Appl. Pharmacol. 167, 157-172] Female mice received 0, 1.5, 15, 150 or 450 ng TCDD/kg/day or approximately 0, 1.5, 15, 150 or 450 ng TEQ/kg/day of MIX-1 or MIX-2 by gavage 5 days per week for 13 weeks. Mice were immunized 3 days after the last exposure and 4 days later, body, spleen, thymus, and liver weights were measured, and antibody response to SRBCs was observed. Exposure to TCDD, MIX-1, and MIX-2 suppressed the antibody response in a dose-dependent manner. Two-way ANOVA indicated no differences in the response between TCDD and the mixtures for body weight, spleen/body weight and decreased antibody responses. The results support the use of the TEF methodology and suggest that immune suppression by dioxin-like chemicals may be of concern at or near background human exposures. FAU - Smialowicz, R J AU - Smialowicz RJ AD - Experimental Toxicology Division, National Health, and Environmental Effects, Research Laboratory, US Environmental Protection Agency, Research Triangle Park, North Carolina 27711, USA. FAU - DeVito, M J AU - DeVito MJ FAU - Williams, W C AU - Williams WC FAU - Birnbaum, L S AU - Birnbaum LS LA - eng PT - Journal Article DEP - 20071203 PL - United States TA - Toxicol Appl Pharmacol JT - Toxicology and applied pharmacology JID - 0416575 RN - 0 (Benzofurans) RN - 0 (Dibenzofurans, Polychlorinated) RN - 0 (Polychlorinated Dibenzodioxins) RN - DFC2HB4I0K (Polychlorinated Biphenyls) RN - EC 1.14.14.1 (Cytochrome P-450 CYP1A1) RN - EC 1.14.14.1 (Cytochrome P-450 CYP1A2) SB - IM MH - Animals MH - Antibody Formation/drug effects MH - Benzofurans/*toxicity MH - Body Weight/drug effects MH - Cytochrome P-450 CYP1A1/analysis/metabolism MH - Cytochrome P-450 CYP1A2/analysis/metabolism MH - Dibenzofurans, Polychlorinated MH - Dose-Response Relationship, Drug MH - Erythrocytes/immunology MH - Female MH - Immune Tolerance/*drug effects MH - Liver/*drug effects/enzymology MH - Mice MH - Mice, Inbred Strains MH - Organ Size/drug effects MH - Polychlorinated Biphenyls/*toxicity MH - Polychlorinated Dibenzodioxins/*analogs & derivatives/toxicity MH - Sheep EDAT- 2008/01/15 09:00 MHDA- 2008/05/06 09:00 CRDT- 2008/01/15 09:00 PHST- 2007/09/28 00:00 [received] PHST- 2007/11/15 00:00 [revised] PHST- 2007/11/19 00:00 [accepted] PHST- 2008/01/15 09:00 [pubmed] PHST- 2008/05/06 09:00 [medline] PHST- 2008/01/15 09:00 [entrez] AID - S0041-008X(07)00520-0 [pii] AID - 10.1016/j.taap.2007.11.018 [doi] PST - ppublish SO - Toxicol Appl Pharmacol. 2008 Mar 15;227(3):477-84. doi: 10.1016/j.taap.2007.11.018. Epub 2007 Dec 3.